Complete heart block during potassium therapy in thyrotoxic periodic paralysis

J Emerg Med. 2013 Jan;44(1):61-4. doi: 10.1016/j.jemermed.2011.05.090. Epub 2012 Jan 4.

Abstract

Background: Although cardiac dysrhythmia is common in patients with thyrotoxic periodic paralysis (TPP), high-degree atrioventricular (AV) block complicated by cardiogenic shock, even under KCl supplementation, is rarely described.

Objectives: To present a case of TPP in a patient who developed complete AV block with severe consequences due to paradoxical hypokalemia during KCl therapy. In addition, the management of acute hypokalemia in TPP is reviewed.

Case report: A 41-year-old Chinese man with TPP presented to the Emergency Department with a 2-day history of paralysis in the extremities. He developed complete AV block with cardiogenic shock and respiratory failure, necessitating ventilatory support when plasma K(+) level decreased from 1.7 mmol/L to 1.3 mmol/L during KCl replacement of 30 mmol in 2 h. The administration of another 60 mmol KCl over 3 h achieved a plasma K(+) level of 2.1 mmol/L, resulting in the resolution of AV block and successful weaning. However, rebound hyperkalemia (K(+) 5.6 mmol/L) upon recovery was evident and uneventfully corrected.

Conclusion: A paradoxical fall in serum K(+) concentration with potentially life-threatening complication is still underappreciated in patients with TPP on KCl supplementation. Early recognition and prompt therapy prevent untoward consequences.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Electrocardiography
  • Heart Block / etiology*
  • Humans
  • Hypokalemic Periodic Paralysis / complications
  • Hypokalemic Periodic Paralysis / drug therapy*
  • Male
  • Potassium Chloride / therapeutic use*

Substances

  • Potassium Chloride